{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-020258","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2022-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.059220+00:00","generated_at":"2026-06-24T09:10:47.548017+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Processa appoints James R. Neal, CEO of XOMA, to board of directors","bullets":["James R. Neal appointed to Processa Board effective July 19, 2022.","Neal is CEO and Chairman of XOMA; also on board of Palisade Bio and Monterey Bio Acquisition.","Appointment brings life sciences and public company experience to Processa board.","Neal will be compensated as per non-employee director program described in May 31, 2022 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-020258","json":"https://secwatch.observer/filing/0001493152-22-020258.json","markdown":"https://secwatch.observer/filing/0001493152-22-020258.md","text":"https://secwatch.observer/filing/0001493152-22-020258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/0001493152-22-020258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:10:47.548017+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ed71b7cf11","claim":"James R. Neal was appointed as Board of Directors at Processa Pharmaceuticals, Inc..","evidence_excerpt":"On July 19, 2022, the Board of Directors of Processa Pharmaceuticals, Inc. (the “Company”) appointed James R. Neal to its Board of Directors, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/0001493152-22-020258-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}